Maximum Ursodiol Dose for a 230-lb (104 kg) Adult
For a 230-lb (104 kg) adult, the maximum safe dose of ursodiol is 2,080 mg/day (20 mg/kg/day), which should never be exceeded due to documented harm at higher doses. 1
Absolute Safety Ceiling
- Do not exceed 20 mg/kg/day under any circumstances; doses of 28–30 mg/kg/day have been associated with significantly worse clinical outcomes including higher rates of liver transplantation, development of varices, and serious adverse events, despite biochemical improvement. 1, 2
- For this 104 kg patient, the absolute maximum is 2,080 mg/day. 1
- A multicenter trial using 28–30 mg/kg/day in PSC was terminated early due to a 2.3-fold increased risk of death, transplantation, or serious endpoints compared to placebo. 2
Indication-Specific Dosing for This Patient
Primary Biliary Cholangitis (PBC)
- Standard dose: 1,352–1,560 mg/day (13–15 mg/kg/day), given in 2–3 divided doses. 3, 4
- This is the FDA-approved and guideline-recommended first-line dose for PBC. 3, 4
- Higher doses up to 20 mg/kg/day have been studied but offer no additional benefit over 13–15 mg/kg/day for PBC. 5
Primary Sclerosing Cholangitis (PSC)
- Recommended range: 1,560–2,080 mg/day (15–20 mg/kg/day) if UDCA is used. 6, 1
- The 2022 EASL guidelines provide only a weak recommendation for UDCA in PSC at 15–20 mg/kg/day, noting it may improve liver tests and surrogate markers but lacks evidence for hard clinical endpoints. 6
- Critical safety warning: The 2010 Hepatology guidelines recommend against routine UDCA use in PSC (Grade 1A recommendation) based on lack of efficacy at standard doses and documented harm at high doses. 7
- Studies using 20–25 mg/kg/day showed some histologic improvement, but the risk-benefit ratio becomes unfavorable above 20 mg/kg/day. 1, 8
Gallstone Dissolution
- Standard dose: 832–1,040 mg/day (8–10 mg/kg/day), given in 2–3 divided doses. 4, 9
- This is the FDA-approved dose for radiolucent gallstone dissolution. 4
- Maximum biliary enrichment with UDCA occurs at approximately 10–12 mg/kg/day, with no additional benefit at higher doses for gallstone dissolution. 9
Gallstone Prevention (Rapid Weight Loss)
- Fixed dose: 600 mg/day (300 mg twice daily), regardless of body weight. 4, 10
- This is the FDA-approved dose for preventing gallstones during rapid weight loss after bariatric surgery. 4
Practical Dosing Calculation for This 104 kg Patient
| Indication | Dose Range (mg/kg/day) | Total Daily Dose (mg/day) | Typical Regimen |
|---|---|---|---|
| PBC (standard) | 13–15 | 1,352–1,560 | 450–500 mg TID |
| PSC (if used) | 15–20 | 1,560–2,080 | 500–700 mg TID |
| Gallstone dissolution | 8–10 | 832–1,040 | 300–350 mg TID |
| Gallstone prevention | Fixed | 600 | 300 mg BID |
| ABSOLUTE MAXIMUM | 20 | 2,080 | Never exceed |
Critical Pitfalls to Avoid
- Never prescribe doses above 20 mg/kg/day: The high-dose PSC trial (28–30 mg/kg/day) demonstrated a 2.3-fold increased risk of reaching primary endpoints (death, transplantation, varices) and 63% serious adverse event rate versus 37% with placebo. 2
- Do not assume "more is better": Biochemical improvement at high doses does not translate to clinical benefit and may cause harm. 2
- PSC dosing controversy: Be aware that older 2010 guidelines recommend against UDCA in PSC entirely, while 2022 EASL guidelines give a weak recommendation for 15–20 mg/kg/day; clinical equipoise exists. 7, 6
- Cost and compliance: In the bariatric surgery population, 45% of patients cited cost as a barrier to UDCA compliance, and 18% experienced nausea. 10
Monitoring Recommendations
- For gallstone dissolution, obtain ultrasound at 6-month intervals during the first year; if no partial dissolution is seen by 12 months, discontinue therapy as success is unlikely. 4
- Monitor liver biochemistries regularly, though improvement in liver tests does not guarantee clinical benefit, particularly in PSC. 2
- After successful gallstone dissolution, stone recurrence occurs in 30% within 2 years and up to 50% within 5 years; serial ultrasonography is recommended. 4